Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, commercial and real world insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share diverse insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health is powered by an authentic, inclusive and high-performance culture that cares for colleagues, customers, patients, communities and the environment.
我们正在追踪 Syneos Health 的市场扩张
新增 营销与公关 活动 — 刚出现 17 个新信号。
Syneos Health 的国际扩张与竞争对手的对比情况
Syneos Health你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Syneos Health你 | 0 | 0 | — | 0 | 0 |
Bus Proc & Perf Analyst
查看职位Buenos Aires, Buenos Aires Province, Argentina · 前天
L&D Trainer
查看职位Buenos Aires, Buenos Aires Province, Argentina · 前天
Clinical Support Specialist
查看职位Buenos Aires, Buenos Aires Province, Argentina · 前天
Incretins. CKM therapies. Combination treatments. Cardiometabolic innovation is advancing rapidly—but complexity is growing just as fast.Discover how our cross-therapeutic model helps sponsors accelerate development in cardiovascular, metabolic and renal programs with greater clarity and speed to market. ...
已结束
The future of cardiometabolic drug development depends on seeing the full picture.Risk doesn't develop in silos and neither should our development strategies.As we head into ADA 2026, I share perspectives on why approaching cardiometabolic disease as an interconnected continuum may help reshape how we think about trial design, risk management and long-term patient outcomes.Read more: Rethinking Risk, Improving Outcomes in Cardiometabolic Drug Development https://lnkd.in/ePUtrRs3If you will be at ...
已结束
Two incredible days of conversations recorded live from the Syneos Health Early Signals podcast booth on the ASCO conference floor 🎙️Over the past 48 hours, I’ve had the opportunity to sit down with leaders across oncology, precision medicine, cell therapy and drug development to discuss the innovations, challenges and breakthroughs shaping what comes next for patients.These are just some of the conversations from the last two days at ASCO, and I’m incredibly grateful to Diana Chen, Nick Glover ...
已结束Veeva Systems的Vault EDC已支持超过1000项试验，20大生物制药公司中8家采用，提高临床数据管理效率。
Telix Pharmaceuticals任命David Gill为非执行董事,于2026年5月11日生效,计划让他担任主席。Gill拥有超过35年生命科学经验。
Crossject与Syneos Health合作在美国推出ZEPIZURE，这是一种使用无针自动注射器技术的紧急癫痫治疗方法。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Syneos Health 的业务、市场和增长信号的快速解答。
